Active ingredientEldecalcitolCat. No. P-E019-001CAS 104121-92-8Family · Pharmaceutical analytical standards
Eldecalcitol
An analogue of calcitriol, the active form of vitamin D, approved in Japan in January 2011 to treat osteoporosis, the disease that makes bones fragile and prone to fracture. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Compared with calcitriol it carries an extra hydroxypropoxy chain on one ring of the molecule, which makes it bind much more tightly to the protein that carries vitamin D in the blood.
Go to the active ingredient →Active ingredientEldecalcitolCat. No. P-E019-001CAS 104121-92-8
Isotopically labelledEldecalcitol-d6Cat. No. P-E019-002CAS 2734920-09-1
ImpurityEldecalcitol Impurity 1Cat. No. P-E019-003
ImpurityEldecalcitol Impurity 2Cat. No. P-E019-004
ImpurityEldecalcitol Impurity 3Cat. No. P-E019-005CAS 2767262-86-0
ImpurityEldecalcitol Tachysterol-FormCat. No. P-E019-006
ImpurityEldecalcitol-Pre-FormCat. No. P-E019-007CAS 201854-22-0
Impuritytrans-EldecalcitolCat. No. P-E019-008CAS 861996-34-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.